BackChromocell Therapeutics Overview

Chromocell Therapeutics Inventory

Chromocell Therapeutics's inventory is $21M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$21.47M

Peer trimmed avg / median

Loading

Chromocell Therapeutics Inventory History

Loading

Chromocell Therapeutics vs. peers: Inventory Comparison

Loading

Chromocell Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chromocell Therapeutics (CHRO) FAQ

Chromocell Therapeutics's inventory stands at $21M as of June 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Chromocell Therapeutics reported $21M in inventory versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in inventory can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Chromocell Therapeutics's inventory evolved across reporting periods, while the comparison chart places CHRO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.